Monod Bio, Inc.

Grantee website Seattle, Washington, United States

Purpose

To develop ultra-sensitive, low-cost, point-of-care TB-LAM test using AI-designed protein binders and optimized lateral-flow formats to improve diagnosis for underserved populations in high-burden, low-resource settings.

Division

Global Health

Date

JULY 2025

Region served

GLOBAL

Committed amount

$1,529,924

Grant topic

Enterics, Diagnostics, Genomics & Epidemiology

Duration (months)

20

Grantee location

Seattle, Washington, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.